Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Heat, cold and environmental emergencies

Essential points for quick revision.

Saved on this device
!
Altered consciousness after heat or cold exposure

Confusion, seizures or unresponsiveness after heat exposure suggest heat stroke; profound cold exposure can produce very slow vital signs and imminent cardiac arrest.

Action: Activate emergency help, ensure safe rescue, assess airway and breathing, measure core temperature and begin rapid appropriate cooling or protected rewarming while organising specialist transfer.

Synopsis

Distinguish life-threatening temperature illness from milder exposure, start effective thermal treatment, and adapt rescue and resuscitation to the environment.

  • Heat stroke is a neurological emergency: confusion after exertion in the heat needs active cooling, even if the person is still sweating.
  • Use core temperature to direct care; a peripheral thermometer can underestimate dangerous thermal disturbance.
  • For suspected heat stroke, start effective available cooling immediately; cold-water immersion is preferred when it can be performed safely.

Reasoning priorities

01
Core temperature

Classify thermal severity and follow the response to cooling or rewarming.

Use a method appropriate to the setting, such as rectal temperature during exertional heat-stroke care or an appropriate low-reading probe in hypothermia. Record the measurement method alongside the value.

Worked reasoning

Worked caseConfusion at the finish line

A runner collapses after a race, remains confused and has a rectal temperature of 40.5°C. The airway is patent and there is no major trauma; a supervised immersion bath is available.

  1. Recognise exertional heat stroke from the neurological change and exposure. Call emergency services, remove excess clothing and appoint someone to maintain the airway and observe the patient continuously.
  2. Start neck-down cold-water immersion without waiting for laboratory tests or transport. Keep the face clear of water and provide practical support so impaired consciousness does not create a drowning risk.
  3. Measure core temperature repeatedly while assessing breathing and circulation. Cooling brings the temperature to 38.8°C with improving cognition; reduce or stop immersion to avoid overshoot and continue clinical assessment.
  4. Verify sustained neurological and haemodynamic recovery and arrange hospital evaluation for renal, muscle, liver and clotting injury. A better temperature does not exclude evolving organ complications.
  5. Document collapse time, starting temperature, cooling method and response. Explain that further exertion is unsafe until medical assessment and a recovery plan are complete.
Local cold injuryFrozen toes after a prolonged outdoor exposure

A person has hard numb toes but is conscious and haemodynamically stable after systemic assessment.

Key medicines

Adrenaline in hypothermic cardiac arrestUnder RCUK 2025, give 1 mg IV once core temperature reaches 30°C unless imminent ECPR is planned; use intervals of 6–10 minutes at 30–35°C. Return to standard ALS intervals after rewarming above this range.This modification applies to accidental hypothermic arrest, not a conscious cold patient with a pulse. Use core temperature and the specialist resuscitation plan; do not administer routine repeated doses below 30°C.
Amiodarone in hypothermic shockable arrestRCUK 2025 permits a 300 mg loading dose for a shockable rhythm under the arrest algorithm, but delays further amiodarone until core temperature exceeds 30°C.If VF persists after three shocks, defer further shocks until core temperature is above 30°C. Do not apply the drug or shock modifications to ordinary normothermic arrest.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom